• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Fibroblast Activation Protein Imaging, An Issue of PET Clinics

Fibroblast Activation Protein Imaging, An Issue of PET Clinics

9780323938952
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
352,75 zł
299,84 zł Zniżka 52,91 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 299,84 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue, guest editors bring their considerable expertise to this important topic.
Szczegóły produktu
Elsevier
99439
9780323938952
9780323938952

Opis

Rok wydania
2023
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
178 x 254
Waga (g)
450
  • Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements

    Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer

    The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma

    Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer

    Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer

    Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer

    Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer

    Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma

    Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma

    Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor

    Imaging Fibrosis

    Cardiac Applications of Fibroblast Activation Protein Imaging

    Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations

    Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment

    Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation

    Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions

Komentarze (0)